Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Oncol.

Sec. Gynecological Oncology

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1532772

This article is part of the Research TopicCuproptosis and Tumors, Volume II: From Basic Research to Clinical TranslationView all 4 articles

Construction of a novel cuproptosis-related gene signature for predicting microenvironment, prognosis and therapeutic response in cervical cancer

Provisionally accepted
Xiao  WangXiao Wang1*Yaqi  CuiYaqi Cui1Zihan  LiuZihan Liu1Kang  MenKang Men1Meng  WangMeng Wang2Yingxin  HuYingxin Hu1Zhiyuan  ZhangZhiyuan Zhang1Xianbin  LiuXianbin Liu3
  • 1Shandong University, Jinan, China
  • 2Qilu Hospital, Shandong University, Jinan, Shandong Province, China
  • 3People’s Hospital of Rizhao, Rizhao, China

The final, formatted version of the article will be published soon.

Cervical cancer is a common malignant tumor in females, and its carcinogenesis needs further elucidation. Cuproptosis is a novel mode of cell death and its role in cervical cancer is largely unknown. We constructed a six-gene signature based on cuproptosis-related genes (CRGs) using consensus clustering analysis which further classified the patients into Cluster A and Cluster B. Kaplan-Meier survival analysis revealed that the prognosis of patients with cervical cancer in Cluster B was significantly better than in Cluster A (p=0.027). By analyzing the differentially expressed genes (DEGs), we optimized the subclassification as high and low DEG score types, and revealed their differences in prognosis, copy number variation and single nucleotide variation. The scoring model showed effectiveness in distinguishing prognosis, tumor staging, immune microenvironment, immunotherapy and chemotherapy sensitivity. Moreover, the overexpression of FOXJ1 (one of the DEGs) significantly decreased the proliferation, invasion, migration and Epithelial-Mesenchymal Transition (EMT) process in cervical cancer cells. FOXJ1 promoted cuproptosis in cervical cancer cells, thereby inhibiting their proliferation, migration, and invasion capabilities. Our study sheds light on the role of cuproptosis in carcinogenesis and is expected to facilitate the development of personalized treatment for cervical cancer.

Keywords: cuproptosis, Tumor Microenvironment, prognosis, Therapeutic response, cervical cancer

Received: 22 Nov 2024; Accepted: 11 Sep 2025.

Copyright: © 2025 Wang, Cui, Liu, Men, Wang, Hu, Zhang and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Xiao Wang, wangxiao08@sdu.edu.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.